Publicaciones en colaboración con investigadores/as de Hospital Vall d'Hebron (8)

2023

  1. Impact of pre- and/or post-autologous stem cell transplantation exposure to brentuximab vedotin on survival outcomes in patients with high-risk Hodgkin lymphoma

    Annals of Hematology, Vol. 102, Núm. 2, pp. 429-437

2022

  1. Prognostic Value of Serum Paraprotein Response Kinetics in Patients With Newly Diagnosed Multiple Myeloma

    Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, Núm. 9, pp. e844-e852

  2. RICORS2040: The need for collaborative research in chronic kidney disease

    Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387

2019

  1. Bendamustine as part of conditioning of autologous stem cell transplantation in patients with aggressive lymphoma: a phase 2 study from the GELTAMO group

    British Journal of Haematology, Vol. 184, Núm. 5, pp. 797-807

  2. Bortezomib, lenalidomide, and dexamethasone as induction therapy prior to autologous transplant in multiple myeloma

    Blood, Vol. 134, Núm. 16, pp. 1337-1345

2018

  1. Circulating extracellular vesicles as potential biomarkers in chronic fatigue syndrome/myalgic encephalomyelitis: an exploratory pilot study

    Journal of Extracellular Vesicles, Vol. 7, Núm. 1

  2. Selective enhancement of domoic acid toxicity in primary cultures of cerebellar granule cells by lowering extracellular Na+ concentration

    Toxicological Sciences, Vol. 161, Núm. 1, pp. 103-114

2011

  1. Lenalidomide treatment for patients with multiple myeloma: Diagnosis and management of most frequent adverse events

    Advances in Therapy, Vol. 28, Núm. SUPPL. 1, pp. 11-16